{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:48:38Z","timestamp":1778888918981,"version":"3.51.4"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Radiology and Cardiovascular Medicine Mayo Clinic Rochester MN USA","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}]},{"name":"Department of Radiology and Cardiovascular Medicine Mayo Clinic Rochester MN USA","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}]},{"name":"Department of Radiology and Cardiovascular Medicine Mayo Clinic Rochester MN USA","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}]},{"name":"Department of Radiology and Cardiovascular Medicine Mayo Clinic Rochester MN USA","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}]},{"name":"Department of Radiology and Cardiovascular Medicine Mayo Clinic Rochester MN USA","award":["Intramural"],"award-info":[{"award-number":["Intramural"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Imaging"],"DOI":"10.1038\/s44303-025-00124-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:01:06Z","timestamp":1764079266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond perfusion: a review of peptide radiopharmaceuticals for cardiovascular imaging"],"prefix":"10.1038","volume":"3","author":[{"given":"Viktoria E.","family":"Krol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna E.","family":"Kusmirek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maliha","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"124_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2016.101","volume":"13","author":"EM Antman","year":"2016","unstructured":"Antman, E. M. & Loscalzo, J. Precision medicine in cardiology. Nat. Rev. Cardiol. 13, 591\u2013602 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"124_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cpcardiol.2006.05.002","volume":"31","author":"RR Russell","year":"2006","unstructured":"Russell, R. R. & Zaret, B. L. Nuclear cardiology: present and future. Curr. Probl. Cardiol. 31, 557\u2013629 (2006).","journal-title":"Curr. Probl. Cardiol."},{"key":"124_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/med.20002","volume":"24","author":"SM Okarvi","year":"2004","unstructured":"Okarvi, S. M. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Med. Res. Rev. 24, 357\u2013397 (2004).","journal-title":"Med. Res. Rev."},{"key":"124_CR4","doi-asserted-by":"publisher","unstructured":"Evans, B. J., King, A. T., Katsifis, A., Matesic, L. & Jamie, J. F. Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals. Molecules https:\/\/doi.org\/10.3390\/molecules25102314 (2020).","DOI":"10.3390\/molecules25102314"},{"key":"124_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103802","volume":"99","author":"F Maleki","year":"2020","unstructured":"Maleki, F., Farahani, A. M., Rezazedeh, F. & Sadeghzadeh, N. Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging. Bioorg. Chem. 99, 103802 (2020).","journal-title":"Bioorg. Chem."},{"key":"124_CR6","doi-asserted-by":"crossref","unstructured":"Davis, R. A., Hausner, S. H. & Sutcliffe, J. L. Peptides as Radiopharmaceutical Vectors. In Radiopharmaceutical Chemistry (eds Lewis, J. S., Windhorst, A. D. & Zeglis B. M.). Ch. 8, 137\u2013162. (Springer International Publishing, 2019).","DOI":"10.1007\/978-3-319-98947-1_8"},{"key":"124_CR7","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2174\/0929867311320150005","volume":"20","author":"P Zhou","year":"2013","unstructured":"Zhou, P., Wang, C., Ren, Y., Yang, C. & Tian, F. Computational peptidology: a new and promising approach to therapeutic peptide design. Curr. Med. Chem. 20, 1985\u20131996 (2013).","journal-title":"Curr. Med. Chem."},{"key":"124_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1039\/C3CS60304K","volume":"43","author":"EW Price","year":"2014","unstructured":"Price, E. W. & Orvig, C. Matching chelators to radiometals for radiopharmaceuticals. Chem. Soc. Rev. 43, 260\u2013290 (2014).","journal-title":"Chem. Soc. Rev."},{"key":"124_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2174\/1871520620666191231161227","volume":"20","author":"AM Farahani","year":"2020","unstructured":"Farahani, A. M., Maleki, F. & Sadeghzadeh, N. The influence of different spacers on biological profile of peptide radiopharmaceuticals for diagnosis and therapy of human cancers. Anticancer Agents Med. Chem. 20, 402\u2013416 (2020).","journal-title":"Anticancer Agents Med. Chem."},{"key":"124_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson, N. C., Rieder, F. & Wynn, T. A. Fibrosis: from mechanisms to medicines. Nature 587, 555\u2013566 (2020).","journal-title":"Nature"},{"key":"124_CR11","doi-asserted-by":"crossref","unstructured":"Higuchi, T., Serfling, S. E., Leistner, D. M., Speer, T. & Werner, R. A. FAPI-PET in Cardiovascular Disease. Semin. Nucl. Med. 54, 747\u2013752 (2024).","DOI":"10.1053\/j.semnuclmed.2024.02.006"},{"key":"124_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","volume":"25","author":"MF Mayola","year":"2023","unstructured":"Mayola, M. F. & Thackeray, J. T. The potential of fibroblast activation protein-targeted imaging as a biomarker of cardiac remodeling and injury. Curr. Cardiol. Rep. 25, 515\u2013523 (2023).","journal-title":"Curr. Cardiol. Rep."},{"key":"124_CR13","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.3390\/cancers13225744","volume":"13","author":"T Lindner","year":"2021","unstructured":"Lindner, T., Giesel, F. L., Kratochwil, C. & Serfling, S. E. Radioligands targeting fibroblast activation protein (FAP). Cancers 13, 5744 (2021).","journal-title":"Cancers"},{"key":"124_CR14","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/cancers15061889","volume":"15","author":"M Martin","year":"2023","unstructured":"Martin, M. et al. Novel Generation of FAP inhibitor-based homodimers for improved application in radiotheranostics. Cancers 15, 1889 (2023).","journal-title":"Cancers"},{"key":"124_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.07.006","volume":"172","author":"R Li","year":"2022","unstructured":"Li, R. & Frangogiannis, N. G. Integrins in cardiac fibrosis. J. Mol. Cell. Cardiol. 172, 1\u201313 (2022).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"124_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/embor.2009.276","volume":"11","author":"C Margadant","year":"2010","unstructured":"Margadant, C. & Sonnenberg, A. Integrin\u2013TGF-\u03b2 crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 11, 97\u2013105 (2010).","journal-title":"EMBO Rep."},{"key":"124_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/cvr\/cvu053","volume":"102","author":"V Sarrazy","year":"2014","unstructured":"Sarrazy, V. et al. Integrins \u03b1v\u03b25 and \u03b1v\u03b23 promote latent TGF-\u03b21 activation by human cardiac fibroblast contraction. Cardiovasc. Res. 102, 407\u2013417 (2014).","journal-title":"Cardiovasc. Res."},{"key":"124_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yjmcc.2015.11.010","volume":"93","author":"C Chen","year":"2016","unstructured":"Chen, C., Li, R., Ross, R. S. & Manso, A. M. Integrins and integrin-related proteins in cardiac fibrosis. J. Mol. Cell. Cardiol. 93, 162\u2013174 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1021\/acs.bioconjchem.5b00327","volume":"26","author":"S Liu","year":"2015","unstructured":"Liu, S. Radiolabeled cyclic RGD peptide bioconjugates as radiotracers targeting multiple integrins. Bioconjugate Chem. 26, 1413\u20131438 (2015).","journal-title":"Bioconjugate Chem."},{"key":"124_CR20","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1021\/bc900167c","volume":"20","author":"S Liu","year":"2009","unstructured":"Liu, S. Radiolabeled cyclic RGD peptides as integrin \u03b1v\u03b23-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjugate Chem. 20, 2199\u20132213 (2009).","journal-title":"Bioconjugate Chem."},{"key":"124_CR21","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.jacc.2008.07.067","volume":"52","author":"SWMVD Borne","year":"2008","unstructured":"Borne, S. W. M. V. D. et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J. Am. Coll. Cardiol. 52, 2017\u20132028 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"124_CR22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s12350-010-9268-5","volume":"17","author":"J Verjans","year":"2010","unstructured":"Verjans, J. et al. Early molecular imaging of interstitial changes in patients after myocardial infarction: comparison with delayed contrast-enhanced magnetic resonance imaging. J. Nucl. Cardiol. 17, 1065\u20131072 (2010).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR23","doi-asserted-by":"publisher","unstructured":"Wu, Q., Song, J., Liu, W., Li, L. & Li, S. Recent advances in positron emission tomography for detecting early fibrosis after myocardial infarction. Front. Cardiovasc. Med. https:\/\/doi.org\/10.3389\/fcvm.2024.1479777 (2024).","DOI":"10.3389\/fcvm.2024.1479777"},{"key":"124_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","volume":"24","author":"AK Barton","year":"2022","unstructured":"Barton, A. K. et al. Emerging molecular imaging targets and tools for myocardial fibrosis detection. Eur. Heart J. Cardiovasc. Imaging 24, 261\u2013275 (2022).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"124_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0002-9440(10)63293-2","volume":"165","author":"AS Antonov","year":"2004","unstructured":"Antonov, A. S., Kolodgie, F. D., Munn, D. H. & Gerrity, R. G. Regulation of macrophage foam cell formation by \u03b1V\u03b23 integrin: potential role in human atherosclerosis. Am. J. Pathol. 165, 247\u2013258 (2004).","journal-title":"Am. J. Pathol."},{"key":"124_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","volume":"57","author":"J Baum","year":"2011","unstructured":"Baum, J. & Duffy, H. S. Fibroblasts and myofibroblasts: what are we talking about?. J. Cardiovasc. Pharmacol. 57, 376\u2013379 (2011).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"124_CR27","doi-asserted-by":"publisher","first-page":"e230098","DOI":"10.1148\/ryct.230098","volume":"6","author":"BE Niego","year":"2024","unstructured":"Niego, B. E. et al. Molecular imaging of diffuse cardiac fibrosis with a radiotracer that targets proteolyzed collagen IV. Radiol. Cardiothorac. Imaging 6, e230098 (2024).","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"124_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1536\/ihj.37.483","volume":"37","author":"K Nogami","year":"1996","unstructured":"Nogami, K. et al. Extracellular matrix components in dilated cardiomyopathy immunohistochernical study of endomyocardial biopsy specimens. Jpn. Heart J. 37, 483\u2013494 (1996).","journal-title":"Jpn. Heart J."},{"key":"124_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2967\/jnumed.122.264530","volume":"64","author":"D Izquierdo-Garcia","year":"2023","unstructured":"Izquierdo-Garcia, D. et al. Biodistribution, dosimetry, and pharmacokinetics of 68Ga-CBP8: a type I collagen\u2013targeted PET probe. J. Nucl. Med. 64, 775\u2013781 (2023).","journal-title":"J. Nucl. Med."},{"key":"124_CR30","doi-asserted-by":"publisher","first-page":"eaaf4696","DOI":"10.1126\/scitranslmed.aaf4696","volume":"9","author":"P D\u00e9sog\u00e8re","year":"2017","unstructured":"D\u00e9sog\u00e8re, P. et al. Type I collagen\u2013targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci. Transl. Med. 9, eaaf4696 (2017).","journal-title":"Sci. Transl. Med."},{"key":"124_CR31","doi-asserted-by":"publisher","first-page":"e034363","DOI":"10.1161\/JAHA.124.034363","volume":"13","author":"BF Moon","year":"2024","unstructured":"Moon, B. F. et al. Simultaneous positron emission tomography and molecular magnetic resonance imaging of cardiopulmonary fibrosis in a mouse model of left ventricular dysfunction. J. Am. Heart Assoc. 13, e034363 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"124_CR32","doi-asserted-by":"publisher","unstructured":"D\u00e9sog\u00e8re, P. et al. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaf4696 (2017).","DOI":"10.1126\/scitranslmed.aaf4696"},{"key":"124_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s44303-024-00037-z","volume":"2","author":"N Chaher","year":"2024","unstructured":"Chaher, N. et al. Non-invasive in vivo imaging of changes in collagen III turnover in myocardial fibrosis. npj Imaging 2, 33 (2024).","journal-title":"npj Imaging"},{"key":"124_CR34","doi-asserted-by":"publisher","unstructured":"Saleh, M. & Ambrose, J. A. Understanding myocardial infarction. F1000Res https:\/\/doi.org\/10.12688\/f1000research.15096.1 (2018).","DOI":"10.12688\/f1000research.15096.1"},{"key":"124_CR35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00259-020-05034-z","volume":"48","author":"MR Makowski","year":"2021","unstructured":"Makowski, M. R. et al. Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin \u03b1v\u03b23 expression and myocardial blood flow. Eur. J. Nucl. Med. Mol. Imaging 48, 1070\u20131080 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"124_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-90","volume":"12","author":"TC Zhao","year":"2013","unstructured":"Zhao, T. C. Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection. Cardiovasc. Diabetol. 12, 90 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"124_CR37","doi-asserted-by":"publisher","first-page":"E630","DOI":"10.1152\/ajpendo.00109.2014","volume":"307","author":"M DeNicola","year":"2014","unstructured":"DeNicola, M. et al. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium. Am. J. Physiol. Endocrinol. Metab. 307, E630\u2013E643 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"124_CR38","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1007\/s12350-018-01547-1","volume":"27","author":"M St\u00e5hle","year":"2020","unstructured":"St\u00e5hle, M. et al. Glucagon-like peptide-1 receptor expression after myocardial infarction: imaging study using 68Ga-NODAGA-exendin-4 positron emission tomography. J. Nucl. Cardiol. 27, 2386\u20132397 (2020).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR39","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2967\/jnumed.112.109413","volume":"53","author":"H Gao","year":"2012","unstructured":"Gao, H. et al. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury. J. Nucl. Med. 53, 1960\u20131968 (2012).","journal-title":"J. Nucl. Med."},{"key":"124_CR40","first-page":"1488","volume":"24","author":"N Mohtavinejad","year":"2021","unstructured":"Mohtavinejad, N., Hajiramezanali, M., Akhlaghi, M., Bitarafan-Rajabi, A. & Gholipour, N. Synthesis and evaluation of (99m)Tc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region. Iran. J. Basic Med. Sci. 24, 1488\u20131499 (2021).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"124_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jvs.2013.06.054","volume":"60","author":"D Joshi","year":"2014","unstructured":"Joshi, D., Abraham, D., Shiwen, X., Baker, D. & Tsui, J. Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia. J. Vasc. Surg. 60, 191\u2013201.e192 (2014).","journal-title":"J. Vasc. Surg."},{"key":"124_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/cvr\/cvaa287","volume":"117","author":"X Wu","year":"2020","unstructured":"Wu, X., Reboll, M. R., Korf-Klingebiel, M. & Wollert, K. C. Angiogenesis after acute myocardial infarction. Cardiovasc. Res. 117, 1257\u20131273 (2020).","journal-title":"Cardiovasc. Res."},{"key":"124_CR43","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s12265-022-10241-0","volume":"15","author":"C Spadaccio","year":"2022","unstructured":"Spadaccio, C. et al. The role of angiogenesis and arteriogenesis in myocardial infarction and coronary revascularization. J. Cardiovasc. Transl. Res. 15, 1024\u20131048 (2022).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"124_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.mvr.2010.03.014","volume":"80","author":"T Zhao","year":"2010","unstructured":"Zhao, T., Zhao, W., Chen, Y., Ahokas, R. A. & Sun, Y. Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc. Res. 80, 188\u2013194 (2010).","journal-title":"Microvasc. Res."},{"key":"124_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-011-9240-2","volume":"15","author":"S Mitsos","year":"2012","unstructured":"Mitsos, S. et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. Angiogenesis 15, 1\u201322 (2012).","journal-title":"Angiogenesis"},{"key":"124_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7150\/thno.4419","volume":"2","author":"L Deveza","year":"2012","unstructured":"Deveza, L., Choi, J. & Yang, F. Therapeutic angiogenesis for treating cardiovascular diseases. Theranostics 2, 801\u2013814 (2012).","journal-title":"Theranostics"},{"key":"124_CR47","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/jcb.30344","volume":"123","author":"A Ahmad","year":"2022","unstructured":"Ahmad, A. & Nawaz, M. I. Molecular mechanism of VEGF and its role in pathological angiogenesis. J. Cell. Biochem. 123, 1938\u20131965 (2022).","journal-title":"J. Cell. Biochem."},{"key":"124_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara, N., Gerber, H.-P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669\u2013676 (2003).","journal-title":"Nat. Med."},{"key":"124_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","volume":"12","author":"C Camar\u00e9","year":"2017","unstructured":"Camar\u00e9, C., Pucelle, M., N\u00e8gre-Salvayre, A. & Salvayre, R. Angiogenesis in the atherosclerotic plaque. Redox Biol. 12, 18\u201334 (2017).","journal-title":"Redox Biol."},{"key":"124_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12410-009-0008-7","volume":"2","author":"M Rodriguez-Porcel","year":"2009","unstructured":"Rodriguez-Porcel, M. Non-invasive monitoring of angiogenesis in cardiology. Curr. Cardiovasc. Imaging Rep. 2, 59\u201366 (2009).","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"124_CR51","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/cells9061358","volume":"9","author":"CI Lang","year":"2020","unstructured":"Lang, C. I. et al. [68Ga]-NODAGA-RGD positron emission tomography (PET) for assessment of post myocardial infarction angiogenesis as a predictor for left ventricular remodeling in mice after cardiac stem cell therapy. Cells 9, 1358 (2020).","journal-title":"Cells"},{"key":"124_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2967\/jnumed.111.091652","volume":"53","author":"HM Sherif","year":"2012","unstructured":"Sherif, H. M. et al. Molecular imaging of early \u03b1v\u03b23 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J. Nucl. Med. 53, 318\u2013323 (2012).","journal-title":"J. Nucl. Med."},{"key":"124_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biomaterials.2015.09.009","volume":"73","author":"C-C Huang","year":"2015","unstructured":"Huang, C.-C. et al. Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction. Biomaterials 73, 12\u201322 (2015).","journal-title":"Biomaterials"},{"key":"124_CR54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/heartjnl-2016-310115","volume":"103","author":"WS Jenkins","year":"2017","unstructured":"Jenkins, W. S. et al. Cardiac \u03b1V\u03b23 integrin expression following acute myocardial infarction in humans. Heart 103, 607\u2013615 (2017).","journal-title":"Heart"},{"key":"124_CR55","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1083\/jcb.152.6.1247","volume":"152","author":"B Troyanovsky","year":"2001","unstructured":"Troyanovsky, B., Levchenko, T., M\u00e5nsson, G., Matvijenko, O. & Holmgren, L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J. Cell Biol. 152, 1247\u20131254 (2001).","journal-title":"J. Cell Biol."},{"key":"124_CR56","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1074\/jbc.M112.446518","volume":"288","author":"J Stalin","year":"2013","unstructured":"Stalin, J. et al. Soluble melanoma cell adhesion molecule (sMCAM\/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin. J. Biol. Chem. 288, 8991\u20139000 (2013).","journal-title":"J. Biol. Chem."},{"key":"124_CR57","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1182\/blood-2009-06-229591","volume":"115","author":"K Harhouri","year":"2010","unstructured":"Harhouri, K. et al. Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood 115, 3843\u20133851 (2010).","journal-title":"Blood"},{"key":"124_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3343\/alm.2016.36.4.300","volume":"36","author":"P Kubena","year":"2016","unstructured":"Kubena, P. et al. Plasma levels of soluble CD146 reflect the severity of pulmonary congestion better than brain natriuretic peptide in acute coronary syndrome. Ann. Lab. Med. 36, 300 (2016).","journal-title":"Ann. Lab. Med."},{"key":"124_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijcard.2015.07.039","volume":"199","author":"E Gayat","year":"2015","unstructured":"Gayat, E. et al. Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. Int. J. Cardiol. 199, 241\u2013247 (2015).","journal-title":"Int. J. Cardiol."},{"key":"124_CR60","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3390\/cells10092305","volume":"10","author":"A Moyon","year":"2021","unstructured":"Moyon, A. et al. Comparison of a new 68Ga-radiolabelled PET imaging agent sCD146 and RGD peptide for in vivo evaluation of angiogenesis in mouse model of myocardial infarction. Cells 10, 2305 (2021).","journal-title":"Cells"},{"key":"124_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0952-8","volume":"18","author":"P Kyriakou","year":"2018","unstructured":"Kyriakou, P. et al. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc. Disord. 18, 221 (2018).","journal-title":"BMC Cardiovasc. Disord."},{"key":"124_CR62","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","volume":"27","author":"MIFJ Oerlemans","year":"2019","unstructured":"Oerlemans, M. I. F. J. et al. Cardiac amyloidosis: the need for early diagnosis. Neth. Heart J. 27, 525\u2013536 (2019).","journal-title":"Neth. Heart J."},{"key":"124_CR63","doi-asserted-by":"publisher","first-page":"B79","DOI":"10.1093\/eurheartjsupp\/suad079","volume":"25","author":"M Emdin","year":"2023","unstructured":"Emdin, M. et al. Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis. Eur. Heart J. Suppl. 25, B79\u2013B84 (2023).","journal-title":"Eur. Heart J. Suppl."},{"key":"124_CR64","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/phar.2639","volume":"41","author":"AL Warner","year":"2021","unstructured":"Warner, A. L. Advances in the treatment of transthyretin cardiac amyloidosis: current and emerging therapies. Pharmacotherapy 41, 1081\u20131091 (2021).","journal-title":"Pharmacotherapy"},{"key":"124_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"E Kastritis","year":"2021","unstructured":"Kastritis, E. et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N. Engl. J. Med. 385, 46\u201358 (2021).","journal-title":"N. Engl. J. Med."},{"key":"124_CR66","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson, M. M. et al. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 81, 1835\u20131878 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"124_CR67","doi-asserted-by":"publisher","first-page":"101207","DOI":"10.1016\/j.blre.2024.101207","volume":"66","author":"J Wang","year":"2024","unstructured":"Wang, J., Li, J. & Zhong, L. Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis. Blood Rev. 66, 101207 (2024).","journal-title":"Blood Rev."},{"key":"124_CR68","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10741-025-10493-3","volume":"30","author":"A Aimo","year":"2025","unstructured":"Aimo, A. et al. Positron emission tomography in cardiac amyloidosis: current evidence and future directions. Heart Fail. Rev. 30, 605\u2013618 (2025).","journal-title":"Heart Fail. Rev."},{"key":"124_CR69","doi-asserted-by":"publisher","unstructured":"Park, Y.-J. et al. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis. BMC Med. Imaging https:\/\/doi.org\/10.1186\/s12880-023-01054-x (2023).","DOI":"10.1186\/s12880-023-01054-x"},{"key":"124_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2022.01.036","volume":"352","author":"U Thelander","year":"2022","unstructured":"Thelander, U. et al. Cardiac microcalcifications in transthyretin (ATTR) amyloidosis. Int. J. Cardiol. 352, 84\u201391 (2022).","journal-title":"Int. J. Cardiol."},{"key":"124_CR71","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini, E. et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J. Am. Coll. Cardiol. 46, 1076\u20131084 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"124_CR72","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.3390\/molecules20057657","volume":"20","author":"JS Wall","year":"2015","unstructured":"Wall, J. S. et al. Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis. Molecules 20, 7657\u20137682 (2015).","journal-title":"Molecules"},{"key":"124_CR73","first-page":"239","volume":"13","author":"T Zhu","year":"2025","unstructured":"Zhu, T. & Pang, H. Progress in the application of positron emission tomography amyloid radiotracers in cardiac amyloidosis. J. Biosci. Med. 13, 239\u2013250 (2025).","journal-title":"J. Biosci. Med."},{"key":"124_CR74","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/ph16040629","volume":"16","author":"EB Martin","year":"2023","unstructured":"Martin, E. B. et al. Clinical confirmation of Pan-amyloid reactivity of radioiodinated peptide 124I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET\/CT imaging. Pharmaceuticals 16, 629 (2023).","journal-title":"Pharmaceuticals"},{"key":"124_CR75","doi-asserted-by":"publisher","first-page":"e0301756","DOI":"10.1371\/journal.pone.0301756","volume":"19","author":"SJ Kennel","year":"2024","unstructured":"Kennel, S. J. et al. Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis. PLoS ONE 19, e0301756 (2024).","journal-title":"PLoS ONE"},{"key":"124_CR76","unstructured":"Attralus Receives Breakthrough Therapy Designation for its Pan-Amyloid Diagnostic PET Imaging Candidate 124Ievuzamitide (AT-01) for Cardiac Amyloidosis. https:\/\/www.globenewswire.com\/news-release\/2024\/08\/05\/2924179\/0\/en\/Attralus-Receives-Breakthrough-Therapy-Designation-for-its-Pan-Amyloid-Diagnostic-PET-Imaging-Candidate-124I-evuzamitide-AT-01-for-Cardiac-Amyloidosis.html (2024)."},{"key":"124_CR77","first-page":"1433","volume":"16","author":"JS Wall","year":"2023","unstructured":"Wall, J. S. et al. Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5+14): a phase 1\/2 study. JACC: Cardiovasc. Imaging 16, 1433\u20131448 (2023).","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"124_CR78","doi-asserted-by":"publisher","unstructured":"Martin, E. B. et al. Longitudinal evaluation of cardiac and extracardiac amyloid load in patients with AL and ATTR amyloidosis, measured by 124I-AT-01 PET\/CT imaging. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad655.236 (2023).","DOI":"10.1093\/eurheartj\/ehad655.236"},{"key":"124_CR79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis, N. G. & Rosenzweig, A. Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159\u2013173 (2012).","journal-title":"Circ. Res."},{"key":"124_CR80","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1093\/ehjci\/jeac167","volume":"23","author":"R Parry","year":"2022","unstructured":"Parry, R. et al. Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review. Eur. Heart J. Cardiovasc. Imaging 23, e504\u2013e525 (2022).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"124_CR81","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","volume":"23","author":"MY Henein","year":"2022","unstructured":"Henein, M. Y., Vancheri, S., Longo, G. & Vancheri, F. The role of inflammation in cardiovascular disease. Int. J. Mol. Sci. 23, 12906 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"124_CR82","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685\u20131695 (2005).","journal-title":"N. Engl. J. Med."},{"key":"124_CR83","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/eurheartj\/ehu225","volume":"36","author":"F Leuschner","year":"2015","unstructured":"Leuschner, F. et al. Silencing of CCR2 in myocarditis. Eur. Heart J. 36, 1478\u20131488 (2015).","journal-title":"Eur. Heart J."},{"key":"124_CR84","doi-asserted-by":"publisher","unstructured":"Finke, D. et al. Early detection of checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET\/CT. Front. Cardiovasc. Med. https:\/\/doi.org\/10.3389\/fcvm.2021.614997 (2021).","DOI":"10.3389\/fcvm.2021.614997"},{"key":"124_CR85","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1007\/s12350-023-03371-8","volume":"30","author":"A Jahandideh","year":"2023","unstructured":"Jahandideh, A. et al. Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis. J. Nucl. Cardiol. 30, 2760\u20132772 (2023).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR86","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1148\/rg.315105222","volume":"31","author":"OG James","year":"2011","unstructured":"James, O. G., Christensen, J. D., Wong, T. Z., Borges-Neto, S. & Koweek, L. M. Utility of FDG PET\/CT in inflammatory cardiovascular disease. Radiographics 31, 1271\u20131286 (2011).","journal-title":"Radiographics"},{"key":"124_CR87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11886-010-0150-5","volume":"13","author":"N Hiari","year":"2011","unstructured":"Hiari, N. & Rudd, J. H. F. FDG PET imaging and cardiovascular inflammation. Curr. Cardiol. Rep. 13, 43\u201348 (2011).","journal-title":"Curr. Cardiol. Rep."},{"key":"124_CR88","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10554-020-02056-4","volume":"37","author":"S Osiecki","year":"2021","unstructured":"Osiecki, S., Sterli\u0144ski, M., Marciniak-Emmons, M. & Dziuk, M. Feasibility of 18 FDG PET in the cardiac inflammation. Int. J. Cardiovasc. Imaging 37, 1097\u20131104 (2021).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"124_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12350-016-0508-1","volume":"24","author":"P Bhambhvani","year":"2017","unstructured":"Bhambhvani, P. Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography. J. Nucl. Cardiol. 24, 100\u2013102 (2017).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tcm.2018.08.004","volume":"29","author":"M Pelletier-Galarneau","year":"2019","unstructured":"Pelletier-Galarneau, M. & Ruddy, T. D. Molecular imaging of coronary inflammation. Trends Cardiovasc. Med. 29, 191\u2013197 (2019).","journal-title":"Trends Cardiovasc. Med."},{"key":"124_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23736\/S1824-4785.20.03230-6","volume":"64","author":"GS Heo","year":"2020","unstructured":"Heo, G. S., Sultan, D. & Liu, Y. Current and novel radiopharmaceuticals for imaging cardiovascular inflammation. Q J. Nucl. Med. Mol. Imaging 64, 4\u201320 (2020).","journal-title":"Q J. Nucl. Med. Mol. Imaging"},{"key":"124_CR92","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","volume":"69","author":"JM Tarkin","year":"2017","unstructured":"Tarkin, J. M. et al. Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F] FDG PET imaging. J. Am. Coll. Cardiol. 69, 1774\u20131791 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"124_CR93","doi-asserted-by":"publisher","first-page":"77807","DOI":"10.18632\/oncotarget.12799","volume":"7","author":"C Lapa","year":"2016","unstructured":"Lapa, C. et al. Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. Oncotarget 7, 77807\u201377814 (2016).","journal-title":"Oncotarget"},{"key":"124_CR94","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s12149-021-01641-4","volume":"35","author":"P Kaushik","year":"2021","unstructured":"Kaushik, P. et al. Comparison of 68Ga-DOTANOC PET\/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis. Ann. Nucl. Med. 35, 1058\u20131065 (2021).","journal-title":"Ann. Nucl. Med."},{"key":"124_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-016-0207-6","volume":"6","author":"LC Gormsen","year":"2016","unstructured":"Gormsen, L. C. et al. A dual tracer 68 Ga-DOTANOC PET\/CT and 18 F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis. EJNMMI Res. 6, 1\u201312 (2016).","journal-title":"EJNMMI Res."},{"key":"124_CR96","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s12350-022-03111-4","volume":"30","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis. J. Nucl. Cardiol. 30, 1075\u20131087 (2023).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR97","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11, 255\u2013265 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"124_CR98","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fendo.2019.00585","volume":"10","author":"EM Garc\u00eda-Cuesta","year":"2019","unstructured":"Garc\u00eda-Cuesta, E. M. et al. The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases. Front. Endocrinol. 10, 585 (2019).","journal-title":"Front. Endocrinol."},{"key":"124_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12350-015-0347-5","volume":"23","author":"C Rischpler","year":"2016","unstructured":"Rischpler, C. et al. Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET\/MRI. J. Nucl. Cardiol. 23, 131\u2013133 (2016).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR100","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2174\/1381612043452640","volume":"10","author":"J Juarez","year":"2004","unstructured":"Juarez, J., Bendall, L. & Bradstock, K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1 \/ CXCR4 axis. Curr. Pharm. Des. 10, 1245\u20131259 (2004).","journal-title":"Curr. Pharm. Des."},{"key":"124_CR101","first-page":"2014","volume":"ume 5","author":"Y Doring","year":"2014","unstructured":"Doring, Y., Pawig, L., Weber, C. & Noels, H. The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease. Front. Physiol. ume 5, 2014 (2014).","journal-title":"Front. Physiol."},{"key":"124_CR102","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.jacc.2011.08.033","volume":"58","author":"EA Liehn","year":"2011","unstructured":"Liehn, E. A. et al. Double-edged role of the CXCL12\/CXCR4 axis in experimental myocardial infarction. J. Am. Coll. Cardiol. 58, 2415\u20132423 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"124_CR103","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/cmdc.201100320","volume":"6","author":"O Demmer","year":"2011","unstructured":"Demmer, O., Gourni, E., Schumacher, U., Kessler, H. & Wester, H. J. PET imaging of CXCR4 receptors in cancer by a new optimized ligand. ChemMedChem 6, 1789\u20131791 (2011).","journal-title":"ChemMedChem"},{"key":"124_CR104","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1021\/jm2009716","volume":"54","author":"O Demmer","year":"2011","unstructured":"Demmer, O. et al. Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4. J. Med. Chem. 54, 7648\u20137662 (2011).","journal-title":"J. Med. Chem."},{"key":"124_CR105","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2967\/jnumed.114.151647","volume":"56","author":"K Herrmann","year":"2015","unstructured":"Herrmann, K. et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor. J. Nucl. Med. 56, 410\u2013416 (2015).","journal-title":"J. Nucl. Med."},{"key":"124_CR106","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","volume":"8","author":"JT Thackeray","year":"2015","unstructured":"Thackeray, J. T. et al. Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc. Imaging 8, 1417\u20131426 (2015).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"124_CR107","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","volume":"41","author":"A Hess","year":"2020","unstructured":"Hess, A. et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur. Heart J. 41, 3564\u20133575 (2020).","journal-title":"Eur. Heart J."},{"key":"124_CR108","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s44161-023-00335-6","volume":"2","author":"KJ Lavine","year":"2023","unstructured":"Lavine, K. J. et al. CCR2 imaging in human ST-segment elevation myocardial infarction. Nat. Cardiovasc. Res. 2, 874\u2013880 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"124_CR109","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1073\/pnas.1406508111","volume":"111","author":"KJ Lavine","year":"2014","unstructured":"Lavine, K. J. et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 111, 16029\u201316034 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"124_CR110","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/CIRCRESAHA.118.314357","volume":"124","author":"B Chen","year":"2019","unstructured":"Chen, B., Brickshawana, A. & Frangogiannis, N. G. The functional heterogeneity of resident cardiac macrophages in myocardial injury. Circ. Res. 124, 183\u2013185 (2019).","journal-title":"Circ. Res."},{"key":"124_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ahj.2011.09.002","volume":"163","author":"AM van der Laan","year":"2012","unstructured":"van der Laan, A. M. et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am. Heart J. 163, 57\u201365. e52 (2012).","journal-title":"Am. Heart J."},{"key":"124_CR112","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","volume":"127","author":"MD Majmudar","year":"2013","unstructured":"Majmudar, M. D. et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 127, 2038\u20132046 (2013).","journal-title":"Circulation"},{"key":"124_CR113","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1111\/ajt.13907","volume":"16","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Noninvasive imaging of CCR2+ cells in ischemia-reperfusion injury after lung transplantation. Am. J. Transplant. 16, 3016\u20133023 (2016).","journal-title":"Am. J. Transplant."},{"key":"124_CR114","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1096\/fj.201500116","volume":"30","author":"C Auvynet","year":"2016","unstructured":"Auvynet, C. et al. ECL1i, d (LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration. FASEB J. 30, 2370\u20132381 (2016).","journal-title":"FASEB J."},{"key":"124_CR115","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","volume":"124","author":"GS Heo","year":"2019","unstructured":"Heo, G. S. et al. Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ. Res. 124, 881\u2013890 (2019).","journal-title":"Circ. Res."},{"key":"124_CR116","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2967\/jnumed.120.244673","volume":"62","author":"GS Heo","year":"2021","unstructured":"Heo, G. S. et al. Targeted PET imaging of chemokine receptor 2\u2013positive monocytes and macrophages in the injured heart. J. Nucl. Med. 62, 111\u2013114 (2021).","journal-title":"J. Nucl. Med."},{"key":"124_CR117","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.arr.2024.102286","volume":"96","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. CCR5 and inflammatory storm. Ageing Res. Rev. 96, 102286 (2024).","journal-title":"Ageing Res. Rev."},{"key":"124_CR118","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","volume":"162","author":"K Jones","year":"2011","unstructured":"Jones, K., Maguire, J. & Davenport, A. Chemokine receptor CCR5: from AIDS to atherosclerosis. Br. J. Pharmacol. 162, 1453\u20131469 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"124_CR119","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1172\/JCI43802","volume":"121","author":"S Potteaux","year":"2011","unstructured":"Potteaux, S. et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe\u2013\/\u2013mice during disease regression. J. Clin. Investig. 121, 2025\u20132036 (2011).","journal-title":"J. Clin. Investig."},{"key":"124_CR120","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Investig. 117, 185\u2013194 (2007).","journal-title":"J. Clin. Investig."},{"key":"124_CR121","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","volume":"17","author":"RE Marques","year":"2013","unstructured":"Marques, R. E., Guabiraba, R., Russo, R. C. & Teixeira, M. M. Targeting CCL5 in inflammation. Expert Opin. Ther. Targets 17, 1439\u20131460 (2013).","journal-title":"Expert Opin. Ther. Targets"},{"key":"124_CR122","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1517\/13543776.16.8.1051","volume":"16","author":"TL Ness","year":"2006","unstructured":"Ness, T. L., Kunkel, S. L. & Hogaboam, C. M. CCR5 antagonists: the answer to inflammatory disease?. Expert Opin. Ther. Pat. 16, 1051\u20131065 (2006).","journal-title":"Expert Opin. Ther. Pat."},{"key":"124_CR123","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3048","volume":"9","author":"RR Koenen","year":"2010","unstructured":"Koenen, R. R. & Weber, C. Therapeutic targeting of chemokine interactions in atherosclerosis. Nat. Rev. Drug Discov. 9, 141\u2013153 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"124_CR124","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12350-018-1248-1","volume":"26","author":"Y Liu","year":"2019","unstructured":"Liu, Y. & Woodard, P. K. Chemokine receptors:key for molecular imaging of inflammation in atherosclerosis. J. Nucl. Cardiol. 26, 1179\u20131181 (2019).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR125","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1570162033352066","volume":"1","author":"MR Ruff","year":"2003","unstructured":"Ruff, M. R. et al. Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors. Curr. HIV Res. 1, 51\u201367 (2003).","journal-title":"Curr. HIV Res."},{"key":"124_CR126","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2967\/jnumed.113.132001","volume":"55","author":"HP Luehmann","year":"2014","unstructured":"Luehmann, H. P. et al. PET\/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle. J. Nucl. Med. 55, 629\u2013634 (2014).","journal-title":"J. Nucl. Med."},{"key":"124_CR127","first-page":"1226","volume":"62","author":"L Detering","year":"2021","unstructured":"Detering, L. et al. CCR5 targeted nanoparticles imaging the progression and regression of atherosclerosis using PET\/CT. J. Nucl. Med. 62, 1226\u20131226 (2021).","journal-title":"J. Nucl. Med."},{"key":"124_CR128","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1021\/acs.molpharmaceut.0c01183","volume":"18","author":"L Detering","year":"2021","unstructured":"Detering, L. et al. CC chemokine receptor 5 targeted nanoparticles imaging the progression and regression of atherosclerosis using positron emission tomography\/computed tomography. Mol. Pharm. 18, 1386\u20131396 (2021).","journal-title":"Mol. Pharm."},{"key":"124_CR129","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s12350-018-1203-1","volume":"26","author":"L Wei","year":"2019","unstructured":"Wei, L. et al. Development of an inflammation imaging tracer, 111In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE\u2212\/\u2212 atherosclerosis mouse model. J. Nucl. Cardiol. 26, 1169\u20131178 (2019).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR130","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.ajpath.2015.05.013","volume":"185","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. \u03b1v\u03b23 Integrins mediate flow-induced NF-\u03baB activation, proinflammatory gene expression, and early atherogenic inflammation. Am. J. Pathol. 185, 2575\u20132589 (2015).","journal-title":"Am. J. Pathol."},{"key":"124_CR131","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/CIRCIMAGING.108.846865","volume":"2","author":"I Laitinen","year":"2009","unstructured":"Laitinen, I. et al. Evaluation of \u03b1v\u03b23 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ. Cardiovasc. Imaging 2, 331\u2013338 (2009).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"124_CR132","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s002590100583","volume":"28","author":"A Signore","year":"2001","unstructured":"Signore, A. et al. Peptide radiopharmaceuticals for diagnosis and therapy. Eur. J. Nucl. Med. 28, 1555\u20131565 (2001).","journal-title":"Eur. J. Nucl. Med."},{"key":"124_CR133","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4070\/kcj.2010.40.7.299","volume":"40","author":"N-H Kim","year":"2010","unstructured":"Kim, N.-H. & Kang, P. M. Apoptosis in cardiovascular diseases: mechanism and clinical implications. Korean Circ. J. 40, 299\u2013305 (2010).","journal-title":"Korean Circ. J."},{"key":"124_CR134","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1071-3581(99)90026-0","volume":"6","author":"F Blankenberg","year":"1999","unstructured":"Blankenberg, F., Narula, J. & Strauss, H. W. In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure. J. Nucl. Cardiol. 6, 531\u2013539 (1999).","journal-title":"J. Nucl. Cardiol."},{"key":"124_CR135","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2004.11.006","volume":"38","author":"S Garg","year":"2005","unstructured":"Garg, S., Narula, J. & Chandrashekhar, Y. Apoptosis and heart failure: clinical relevance and therapeutic target. J. Mol. Cell. Cardiol. 38, 73\u201379 (2005).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"124_CR136","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GR De Meyer","year":"2024","unstructured":"De Meyer, G. R., Zurek, M., Puylaert, P. & Martinet, W. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat. Rev. Cardiol. 21, 312\u2013325 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"124_CR137","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.2174\/0929867327666200612152655","volume":"27","author":"M Mosayebnia","year":"2020","unstructured":"Mosayebnia, M., Hajiramezanali, M. & Shahhosseini, S. Radiolabeled peptides for molecular imaging of apoptosis. Curr. Med. Chem. 27, 7064\u20137089 (2020).","journal-title":"Curr. Med. Chem."},{"key":"124_CR138","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.14730 (2017).","DOI":"10.18632\/oncotarget.14730"},{"key":"124_CR139","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10495-019-01523-1","volume":"24","author":"M Wuest","year":"2019","unstructured":"Wuest, M., Perreault, A., Richter, S., Knight, J. C. & Wuest, F. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis. Apoptosis 24, 221\u2013244 (2019).","journal-title":"Apoptosis"},{"key":"124_CR140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41181-016-0021-5","volume":"2","author":"R Ben Azzouna","year":"2017","unstructured":"Ben Azzouna, R. et al. Synthesis, gallium labelling and characterization of P04087, a functionalized phosphatidylserine-binding peptide. EJNMMI Radiopharm. Chem. 2, 3 (2017).","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"124_CR141","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/cbdd.13773","volume":"97","author":"H Tan","year":"2021","unstructured":"Tan, H. et al. 99mTc-labeled duramycin for detecting and monitoring cardiomyocyte death and assessing atorvastatin cardioprotection in acute myocardial infarction. Chem. Biol. Drug Des. 97, 210\u2013220 (2021).","journal-title":"Chem. Biol. Drug Des."},{"key":"124_CR142","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jcmg.2020.01.010","volume":"13","author":"F Chaudhry","year":"2020","unstructured":"Chaudhry, F. et al. Molecular imaging of cardiac allograft rejection. JACC Cardiovasc. Imaging 13, 1438\u20131441 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"124_CR143","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nucmedbio.2016.05.007","volume":"43","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin. Nucl. Med. Biol. 43, 496\u2013505 (2016).","journal-title":"Nucl. Med. Biol."},{"key":"124_CR144","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jcmg.2017.12.009","volume":"11","author":"JC Wu","year":"2018","unstructured":"Wu, J. C., Qin, X. & Neofytou, E. Radiolabeled duramycin. JACC Cardiovasc. Imaging 11, 1834\u20131836 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"124_CR145","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/bab.2233","volume":"69","author":"M Asadi","year":"2022","unstructured":"Asadi, M. et al. Caspase-3: structure, function, and biotechnological aspects. Biotechnol. Appl. Biochem. 69, 1633\u20131645 (2022).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"124_CR146","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11307-013-0644-9","volume":"15","author":"H Su","year":"2013","unstructured":"Su, H. et al. Evaluation of [18F]-CP18 as a PET imaging tracer for apoptosis. Mol. Imaging Biol. 15, 739\u2013747 (2013).","journal-title":"Mol. Imaging Biol."},{"key":"124_CR147","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P. K. & Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900\u2013905 (1998).","journal-title":"N. Engl. J. Med."},{"key":"124_CR148","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.114.001952","volume":"8","author":"H Su","year":"2015","unstructured":"Su, H. et al. Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity. Circ. Cardiovasc. Imaging 8, e001952 (2015).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"124_CR149","doi-asserted-by":"publisher","first-page":"A18681","DOI":"10.1161\/circ.126.suppl_21.A18681","volume":"126","author":"BK Tamarappoo","year":"2012","unstructured":"Tamarappoo, B. K. et al. Abstract 18681: molecular imaging of angiogenesis in atherosclerosis using a caspase 3 targeted PET tracer 18F-CP18. Circulation 126, A18681\u2013A18681 (2012).","journal-title":"Circulation"},{"key":"124_CR150","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/ph16060824","volume":"16","author":"S Settelmeier","year":"2023","unstructured":"Settelmeier, S. et al. Demonstration of the early cardiac bioavailability of a non-specific cell-targeted peptide using radionuclide-based imaging in vivo. Pharmaceuticals 16, 824 (2023).","journal-title":"Pharmaceuticals"},{"key":"124_CR151","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/biom13121690","volume":"13","author":"D Sahagun","year":"2023","unstructured":"Sahagun, D. & Zahid, M. Cardiac-targeting peptide: from discovery to applications. Biomolecules 13, 1690 (2023).","journal-title":"Biomolecules"},{"key":"124_CR152","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/biom8040147","volume":"8","author":"M Zahid","year":"2018","unstructured":"Zahid, M. et al. Cardiac targeting peptide, a novel cardiac vector: studies in bio-distribution, imaging application, and mechanism of transduction. Biomolecules 8, 147 (2018).","journal-title":"Biomolecules"},{"key":"124_CR153","first-page":"P1066","volume":"64","author":"M Pandey","year":"2023","unstructured":"Pandey, M. et al. Synthesis and evaluation of novel [68Ga]Ga-NOTA-CTP in normal CD-1 mice as a myocardial perfusion imaging PET probe. J. Nucl. Med. 64, P1066\u2013P1066 (2023).","journal-title":"J. Nucl. Med."},{"key":"124_CR154","first-page":"242196","volume":"65","author":"SR Gundam","year":"2024","unstructured":"Gundam, S. R. et al. Evaluation of [68Ga]Ga-NOTA-CTP in CD1 mice with myocardial infarction. J. Nucl. Med. 65, 242196\u2013242196 (2024).","journal-title":"J. Nucl. Med."},{"key":"124_CR155","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1039\/D5PM00047E","volume":"2","author":"S Gundam","year":"2025","unstructured":"Gundam, S. et al. Synthesis and preliminary evaluation of cardiac imaging with [68Ga] Ga-NOTA-CTP in normal and infarcted CD1 mice. RSC Pharmaceutics 2, 691\u2013702 (2025).","journal-title":"RSC Pharmaceutics"},{"key":"124_CR156","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.7150\/thno.100116","volume":"14","author":"SA Esfahani","year":"2024","unstructured":"Esfahani, S. A. et al. Collagen type I PET\/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Theranostics 14, 5745\u20135761 (2024).","journal-title":"Theranostics"},{"key":"124_CR157","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.nucmedbio.2012.02.006","volume":"39","author":"K Pohle","year":"2012","unstructured":"Pohle, K. et al. 68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP\/GRP compliant automated process. Nucl. Med. Biol. 39, 777\u2013784 (2012).","journal-title":"Nucl. Med. Biol."},{"key":"124_CR158","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7150\/thno.13242","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen, H., Niu, G., Wu, H. & Chen, X. Clinical application of radiolabeled RGD peptides for PET imaging of integrin \u03b1v\u03b23. Theranostics 6, 78\u201392 (2016).","journal-title":"Theranostics"},{"key":"124_CR159","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11307-015-0914-9","volume":"18","author":"SJ Kennel","year":"2016","unstructured":"Kennel, S. J., Stuckey, A., McWilliams-Koeppen, H. P., Richey, T. & Wall, J. S. Tc-99m radiolabeled peptide p5\u2009+\u200914 is an effective probe for SPECT imaging of systemic amyloidosis. Mol. Imaging Biol. 18, 483\u2013489 (2016).","journal-title":"Mol. Imaging Biol."},{"key":"124_CR160","doi-asserted-by":"publisher","unstructured":"Huo, L., \u00d6kesli, A., Zhao, M. & van der Donk, W. A. Insights into the biosynthesis of duramycin. Appl. Environ. Microbiol. https:\/\/doi.org\/10.1128\/aem.02698-16 (2017).","DOI":"10.1128\/aem.02698-16"}],"container-title":["npj Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00124-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:06:40Z","timestamp":1764083200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00124-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1038\/s44303-025-00124-9","relation":{},"ISSN":["2948-197X"],"issn-type":[{"value":"2948-197X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}